Echosens

Industry · 12 registered clinical trials — 3 currently recruiting.

Status	Trial	Phase	Started
Not Yet Recruiting	Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP) Heart Failure, Heart Failure - NYHA II - IV	N/A	2026-01-15
Recruiting	Development of a FibroScan Liver Examination Using a Single Probe Liver Diseases	N/A	2025-11-14
Completed	FibroScan-Reproducibility and Repeatability Study Non-Alcoholic Fatty Liver Disease, Liver Disease; Alcohol-Related	N/A	2025-07-16
Recruiting	Development of a New Method for Liver Stiffness Measurement Using FibroScan Liver Diseases	N/A	2024-11-08
Completed	Validation of the New Vibration-guided FibroScan Examination Liver Diseases	N/A	2022-10-26
Terminated	Optimization of Spleen VCTE Examinations with FibroScan Spleen; Fibrosis	N/A	2022-06-01
Completed	Development of Predictive Indicators of Homogeneous Propagation of Ultrasound and Elastic Waves During VCTE Ex Liver Fibrosis	N/A	2021-04-06
Completed	Validation of the Second Generation of the Controlled Attenuation Parameter (CAP) Using the MRI-PDFF as Refere Chronic Liver Disease	N/A	2019-09-24
Completed	Performances Evaluation of New FibroScan Probes Dedicated to Morbidly Obese Patients Obesity, Morbid, Liver Fibrosis	N/A	2019-09-19
Completed	Prospective, Cross-sectional and Multicenter Study, Evaluating the Diagnosis Accuracy of the Controlled Attenu Non-alcoholic Fatty Liver Disease	N/A	2014-01-01
Completed	Spleen Stiffness Measurement With FibroScan Cirrhosis	N/A	2012-03-01
Completed	Fibroscan® and Its Dedicated Probes Efficiency in Obese Patients Liver Fibrosis, Cirrhosis	N/A	2009-07-01